Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2025 | Comparable survival outcomes in HLA-matched vs haploidentical SCT for patients with SAA

Zhengli Xu • 13 Jun 2025
EHA 2025
Aplastic Anemia

In this interview, Zhengli Xu, MD, Peking University People’s Hospital, Beijing, China, discusses advances in stem cell transplantation (SCT) for patients with severe aplastic anemia (SAA), highlighting a study comparing HLA-matched versus haploidentical SCT in this patient population. This video is provided courtesy of TalkMED, in collaboration with Magdalen Medical Publishing (MMP). The interview was recorded at the 30th Congress of the European Hematology Association (EHA) in Milan, Italy.

These works are protected by copyright laws and treaties around the world. All rights are reserved.

Related Videos

Treating patients with PNH and bone marrow failure 0:58
Treating patients with PNH and bone marrow failure
Jeff Szer • 15 May 2025
Bridging therapy options for patients with aplastic anemia and selecting between them 3:02
Bridging therapy options for patients with aplastic anemia and selecting between them
Juan Montoro • 26 Mar 2025
The impact of donor types in alloSCT with PTCy for severe aplastic anemia 2:42
The impact of donor types in alloSCT with PTCy for severe aplastic anemia
Juan Montoro • 26 Mar 2025
Factors to consider when selecting a patient with aplastic anemia for transplantation 3:47
Factors to consider when selecting a patient with aplastic anemia for transplantation
Juan Montoro • 26 Mar 2025
The content of VJHemOnc is intended for healthcare professionals